Sickle cell disorders (SCD) are rare hematologic genetic disorders that, in their severe forms, are associated with chronic, life-impairing and -threatening conditions with inherent serious health sequelae that can lead to disability or even death. Although SCD are traditionally endemic in African and Middle East countries, their frequency have increseased recently worldwide due to migration and mobility flows, becoming a growing global health problem and a challenge to be tackled by European healthcare systems.
On the occasion of SCD World Day, the International day of SCD meeting for patients and carers was held last 19th June coorganized by the Belgian Hematology Society and ERN-EuroBloodNet in Brussels. The meeting specially addressed the current action being implemented by ERN-EuroBloodNet for the creation of the European network of SCD patients organizations.
Béatrice Gulbis, ERN-EuroBloodNet co-coordinator highlighted the importance of having a joint meeting with patients in order "to ensure that we can work altogether in the creation of the network of the different patients organizations. It is very important to have the voice within Belgium regarding all politics, authorities, stakeholders, but also from the patients' themselves so they can meet together and share the actions they want to do regarding the disease. Accordingly, we organized this meeting with all of them including different topics regarding the creation of the network. I think it is a very good opportunity also to encourage them to be involved in this action through ERN-EuroBloodNet."
In this context, we are happy to announce the main actions currently ongoing under the framework of ERN-EuroBloodNet in order to improve the diagnosis, treatment and management of SCD patients. Happy SCD World Day!